Federated Hermes’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Federated Hermes’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-71,587	Closed	-$3.86M	–	2296
2017 Q4	$3.86M	Buy	71,587 +4,356	+6%	+$238K	0.01%	695
2017 Q3	$3.84M	Buy	67,231 +7,332	+12%	+$429K	0.01%	652
2017 Q2	$3.6M	Sell	59,899 -5,252	-8%	-$299K	0.01%	679
2017 Q1	$3.55M	Buy	+65,151	New	+$3.21M	0.01%	696

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Federated Hermes's BIVV Position: Q1 2018 in Review

Federated Hermes sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 71,587 shares — an estimated $3.86M sold.

Federated Hermes first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $3.86M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Federated Hermes reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Federated Hermes sold 71,587 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $3.86M.
Federated Hermes first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Federated Hermes's Bioverativ Inc. Common Stock position peaked at $3.86M in Q4 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Federated Hermes's 13F filing for Q1 2018, filed 9 May 2018.